Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126151911 | 12615191 | 1 | I | 20160712 | 20160802 | 20160802 | PER | US-PFIZER INC-2016344154 | PFIZER | 65.00 | YR | F | Y | 59.00000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126151911 | 12615191 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK UNK, AS NEEDED(300 MG, ONE TO TWO CAPSULES IN EVERY 8 HOURS AS NEEDED) | 20235 | CAPSULE, HARD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126151911 | 12615191 | 1 | Neuralgia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126151911 | 12615191 | Drug ineffective for unapproved indication | |
126151911 | 12615191 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126151911 | 12615191 | 1 | 20160426 | 20160516 | 0 |